FDA approval boosts weight loss pill co Epitomee

Dr. Shimon Eckhouse  credit: Tomer Shalom
Dr. Shimon Eckhouse credit: Tomer Shalom

Epitomee's product expands in the stomach, giving a sense of satiety. The big challenge now will be marketing.

Epitomee Medical (TASE: EPIT), chaired by serial biomed entrepreneur Shimon Eckhouse, has announced the receipt of US Federal Drug Administration (FDA) approval for the sale of its weight management pill in the US. The pill expands in the stomach, giving a sense of satiety.

Following the report, Epitomee’s share price shot up by 152% yesterday, and is up by a further 27% so far today. The company’s market cap at yesterday’s close was NIS 232 million, still 75% below its valuation in its flotation on the Tel Aviv Stock Exchange in December 2021.

The FDA approval was fairly predictable. The real challenge will be in marketing the product (the company has yet to record sales). Epitomee was to have entered the slimming market with food giant Nestlé, but the latter withdrew from the marketing agreement between the companies at the end of 2023, which is what led to the drop in Epitomee’s share price. Nestlé said that although results of clinical trials of the pill indicated a statistically significant, and substantial, weight loss from its use, they were not sufficient for it to stand behind marketing of the product.

The background to Nestlé’s decision was significant changes that had taken place in the market for obesity prevention products since Epitomee was founded, and even since its flotation. Eli Lilly and Novo Nordisk brought weight-loss inducing drugs to the market that were much more effective than anything seen before them, and more effective than Epitomee’s pill.

In Epitomee’s trial, 27% of patients lost at least 10% of their body weight, and more than 10% lost at least 15%. Eli Lilly’s drug, at high dosage, led to a weight loss of 20% or more for over half of the participants in its trial.

Epitomee has said in the past that its product is aimed at people with a low to medium degree of obesity, and those who fear the side effects of weight-loss drugs. Besides this, Epitomee CEO Dan Hashimshony stressed, talking to "Globes", that Epitomee’s pill is swallowed, whereas other treatments are administered by injection.

"Our intention now is to sign a number of agreements with distributors," Hashimshony said. "In the US, we shall work with a single distributor for each state, and in Europe with strong local distributors in each country, even if they are not well known internationally. The agreements will be classic distribution agreements, and we will announce them gradually from today until the product launch in the third quarter of 2025, and even after that."

At the end of June, Epitomee had liquid balances of $29 million, after accumulating losses of $65 million since it was founded. In the first half of this year, the company used $4.3 million for its regular operations, and, according to Hashimshony, it has sufficient cash to complete its production facility and to launch the product.

Published by Globes, Israel business news - en.globes.co.il - on September 16, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Dr. Shimon Eckhouse  credit: Tomer Shalom
Dr. Shimon Eckhouse credit: Tomer Shalom
Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018